FRACASSI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 3.627
EU - Europa 3.572
AS - Asia 2.557
SA - Sud America 396
AF - Africa 80
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.241
Nazione #
US - Stati Uniti d'America 3.551
RU - Federazione Russa 1.299
SG - Singapore 1.038
GB - Regno Unito 891
CN - Cina 676
IT - Italia 372
BR - Brasile 321
SE - Svezia 214
VN - Vietnam 207
HK - Hong Kong 191
DE - Germania 184
FR - Francia 152
FI - Finlandia 147
IE - Irlanda 145
BD - Bangladesh 102
KR - Corea 74
TR - Turchia 64
JP - Giappone 51
IN - India 49
UA - Ucraina 42
CA - Canada 39
AR - Argentina 27
IQ - Iraq 24
NL - Olanda 21
AT - Austria 19
MX - Messico 19
BE - Belgio 17
ZA - Sudafrica 17
ES - Italia 16
EC - Ecuador 15
NG - Nigeria 14
NP - Nepal 14
ID - Indonesia 12
PK - Pakistan 11
PL - Polonia 11
BJ - Benin 8
CO - Colombia 8
PE - Perù 8
CZ - Repubblica Ceca 7
EG - Egitto 7
MA - Marocco 7
SA - Arabia Saudita 7
AU - Australia 6
IR - Iran 6
JM - Giamaica 6
LT - Lituania 6
TG - Togo 6
CH - Svizzera 5
GR - Grecia 5
KE - Kenya 5
PY - Paraguay 5
VE - Venezuela 5
CL - Cile 4
LB - Libano 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BO - Bolivia 3
RO - Romania 3
SI - Slovenia 3
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
BW - Botswana 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
KW - Kuwait 2
PH - Filippine 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BT - Bhutan 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
Totale 10.235
Città #
Southend 767
Singapore 578
Moscow 455
Ashburn 404
San Jose 372
Chandler 329
Dallas 321
Jacksonville 288
Hong Kong 187
Ann Arbor 174
Dublin 145
Woodbridge 132
Verona 125
Beijing 124
The Dalles 108
Houston 101
New York 88
Los Angeles 83
Council Bluffs 81
Ho Chi Minh City 73
Lawrence 54
Princeton 54
Wilmington 53
Jinan 49
Hanoi 48
Tokyo 47
Milan 39
Munich 39
Nanjing 37
Shenyang 36
São Paulo 34
Helsinki 33
Redmond 30
Buffalo 27
Redondo Beach 24
Santa Clara 23
Turku 23
London 20
Zhengzhou 20
Columbus 19
Tianjin 19
Ningbo 18
Orem 18
Haikou 17
Hebei 17
Brussels 16
Changsha 16
Boardman 15
Brooklyn 15
Sindelfingen 15
Abuja 14
Amsterdam 14
Atlanta 14
Falkenstein 14
Fuzhou 14
Taizhou 14
Boston 13
Jiaxing 13
Montreal 13
Taiyuan 13
Chicago 12
Johannesburg 12
Redwood City 12
Rio de Janeiro 12
Baghdad 11
Kathmandu 11
Nanchang 11
Phoenix 11
San Francisco 11
Chennai 10
Da Nang 10
Denver 10
Frankfurt am Main 10
Guangzhou 10
Lappeenranta 10
Seattle 10
Washington 10
Düsseldorf 9
Hangzhou 9
Lancaster 9
Orani 9
Poplar 9
Rome 9
Vienna 9
Ankara 8
Belo Horizonte 8
Cagliari 8
Cotonou 8
Jakarta 8
Stockholm 8
Detroit 7
Manchester 7
Mexico City 7
Norwalk 7
Sanayi 7
Toronto 7
Warsaw 7
Brasília 6
Charlotte 6
Dongguan 6
Totale 6.307
Nome #
Artrite Reumatoide e Metabolismo Minerale 271
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 271
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 254
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 244
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 214
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 210
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 208
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 206
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 201
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 187
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 181
Osteopetrosi 177
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 176
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 171
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 169
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 168
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 167
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 167
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 167
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 165
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 165
Sclerostin and DKK1 in primary hyperparathyroidism. 164
Artropatie degenerative 162
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 161
Prevalence of osteoporosis in patients affected by mastocytosis 157
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 156
Development and First Validation of a Disease Activity Score for Gout 156
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 152
Invecchiamento dell'apparato scheletrico 151
Focal bone involvement in inflammatory arthritis: the role of IL17 146
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 145
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 143
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 141
Vitamina D e artrite reumatoide 140
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 139
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 138
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 138
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 138
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 137
Changes in bone turnover markers and bone modulators during abatacept treatment 136
Osteoporosi 132
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 131
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 129
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 127
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 127
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 126
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 125
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 123
Neridronic acid for the treatment of bone metabolic diseases 122
Vitamin D and rheumatic diseases. 122
Osteoporosis Treatment: When to Discontinue and When to Re-start 120
Vitamin D and fractures: a systematic review 116
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 113
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 113
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 112
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 111
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis 109
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. 106
Risk factors for hip fracture in elderly persons 102
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 95
Risk factors for hip fracture in elderly persons 94
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis 94
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 93
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 92
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. 91
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 90
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 90
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study 88
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 87
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 86
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis,Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile 85
Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report 66
Coping strategies, depression, anxiety and fatigue in rheumatic diseases: A moderated mediation analysis 2
Totale 10.358
Categoria #
all - tutte 34.734
article - articoli 31.753
book - libri 0
conference - conferenze 670
curatela - curatele 0
other - altro 442
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.869
Totale 69.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/2022459 23 147 12 13 27 19 7 23 44 7 38 99
2022/2023998 70 107 84 177 54 244 11 68 122 17 33 11
2023/2024539 23 30 43 53 70 94 23 65 7 14 75 42
2024/20251.499 71 79 73 223 79 60 90 66 223 133 129 273
2025/20264.618 306 256 321 828 1.104 316 448 237 283 214 146 159
Totale 10.358